Literature DB >> 28485042

Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study.

Luca Ceriani1, Maurizio Martelli2, Annarita Conconi3, Pier L Zinzani4, Andrés J M Ferreri5, Barbara Botto6, Caterina Stelitano7, Manuel Gotti8, Maria G Cabras9, Luigi Rigacci10, Luca Giovanella1, Emanuele Zucca1, Peter W M Johnson11.   

Abstract

The International Extranodal Lymphoma Study Group-26 study evaluated the prognostic role of 18-fluorodeoxyglucose positron-emission tomography (PET) in primary mediastinal large B-cell lymphoma. We assessed quantitative PET parameters at diagnosis and post-treatment in 100 patients. The end-of-therapy total lesion glycolysis (TLG) was the best individual outcome predictor, but the combination of baseline TLG and end-of-therapy visual analysis with Deauville Score (DS) showed a better positive predictive value. A model in which baseline TLG is combined with interim DS might identify patients with shorter progression-free survival. PET metrics combined with interim DS may allow early risk assessment and warrants further studies.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  positron-emission tomography; positron-emission tomography metrics; primary mediastinal B-cell lymphoma; prognostic factors; total lesion glycolysis

Mesh：

Substances：

Year:  2017        PMID： 28485042     DOI： 10.1111/bjh.14728

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  7 in total

1.  Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.

Authors:  Theodoros P Vassilakopoulos; Michail Michail; Sotirios Papageorgiou; Georgia Kourti; Maria K Angelopoulou; Fotios Panitsas; Sotirios Sachanas; Christina Kalpadakis; Eirini Katodritou; Theoni Leonidopoulou; Ioannis Kotsianidis; Eleftheria Hatzimichael; Maria Kotsopoulou; Maria Dimou; Eleni Variamis; Dimitrios Boutsis; Evangelos Terpos; Maria N Dimopoulou; Stamatios Karakatsanis; Eurydiki Michalis; George Karianakis; Pantelis Tsirkinidis; Chryssa Vadikolia; Christos Poziopoulos; Anna Pigaditou; Effimia Vrakidou; Theophanis Economopoulos; Lydia Kyriazopoulou; Marina P Siakantaris; Marie-Christine Kyrtsonis; Argyris Symeonidis; Konstantinos Anargyrou; Maria Papaioannou; Evdoxia Hatjiharissi; Elissavet Vervessou; Maria Tsirogianni; Maria Palassopoulou; Gabriella Gainaru; Ekaterini Stefanoudaki; Panayiotis Zikos; Panayiotis Tsirigotis; Gerasimos Tsourouflis; Theodora Assimakopoulou; Pavlina Konstantinidou; Helen A Papadaki; Katerina Megalakaki; Meletios-Athanasios Dimopoulos; Vassiliki Pappa; Themis Karmiris; Paraskevi Roussou; Panayiotis Panayiotidis; Kostas Konstantopoulos; Gerassimos A Pangalis
Journal:  Oncologist       Date:  2021-06-17

Review 2.  How I treat primary mediastinal B-cell lymphoma.

Authors:  Lisa Giulino-Roth
Journal:  Blood       Date:  2018-07-05       Impact factor: 22.113

3.  Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.

Authors:  Chelsea C Pinnix; Andrea K Ng; Bouthaina S Dabaja; Sarah A Milgrom; Jillian R Gunther; C David Fuller; Grace L Smith; Zeinab Abou Yehia; Wei Qiao; Christine F Wogan; Mani Akhtari; Osama Mawlawi; L Jeffrey Medeiros; Hubert H Chuang; William Martin-Doyle; Philippe Armand; Ann S LaCasce; Yasuhiro Oki; Michelle Fanale; Jason Westin; Sattva Neelapu; Loretta Nastoupil
Journal:  Blood Adv       Date:  2018-06-12

Review 4.  Primary mediastinal large B cell lymphoma.

Authors:  Yating Yu; Xifeng Dong; Meifeng Tu; Huaquan Wang
Journal:  Thorac Cancer       Date:  2021-09-29       Impact factor: 3.500

5.  Multiparameter diagnostic model based on 18F-FDG PET and clinical characteristics can differentiate thymic epithelial tumors from thymic lymphomas.

Authors:  Guanyun Wang; Lei Du; Xia Lu; Jiajin Liu; Mingyu Zhang; Yue Pan; Xiaolin Meng; Xiaodan Xu; Zhiwei Guan; Jigang Yang
Journal:  BMC Cancer       Date:  2022-08-16       Impact factor: 4.638

6.  End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making.

Authors:  Christopher Melani; Ranjana Advani; Mark Roschewski; Kelsey M Walters; Clara C Chen; Lucia Baratto; Mark A Ahlman; Milos D Miljkovic; Seth M Steinberg; Jessica Lam; Margaret Shovlin; Kieron Dunleavy; Stefania Pittaluga; Elaine S Jaffe; Wyndham H Wilson
Journal:  Haematologica       Date:  2018-05-10       Impact factor: 9.941

Review 7.  Whole-Body Magnetic Resonance Imaging: Current Role in Patients with Lymphoma.

Authors:  Domenico Albano; Giuseppe Micci; Caterina Patti; Federico Midiri; Silvia Albano; Giuseppe Lo Re; Emanuele Grassedonio; Ludovico La Grutta; Roberto Lagalla; Massimo Galia
Journal:  Diagnostics (Basel)       Date:  2021-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.